...
首页> 外文期刊>Journal of nanoscience and nanotechnology >Effect of Hydroxyapatite Nanoparticles on the Growth Potential of Hepatoma Cells in Nude Mice
【24h】

Effect of Hydroxyapatite Nanoparticles on the Growth Potential of Hepatoma Cells in Nude Mice

机译:羟基磷灰石纳米颗粒对裸鼠肝癌细胞生长潜力的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Aim: To evaluate the activity of hydroxyapatite (HAP) nanoparticles against the proliferation of hepatoma cells. Methods: HAP nanoparticles were prepared by homogeneous precipitation. The size distribution and morphology of these nanoparticles were determined by laser particle analysis and transmission electron microscopy, respectively. Xenograft tumor models of human hepatoma cells (Bel-7402) implanted in nude mice under the right scruff skin were established and divided into two groups: treatment and control. Once the xenograft tumor grew to a diameter of 0.8 cm, 0.2 ml HAP nanoparticle suspension was injected into the tumor every day for 2 weeks. The long and short diameters of the tumors were measured before and after HAP injection, and the inhibition rate of tumor growth was calculated. Paraffin tissue sections were prepared from xenograft tumors treated as above for 2 weeks, histologically stained for DNA and agyrophilic nucleolar organizer region (AgNORs), and imnnuno-histologically stained for proliferating cell nuclear antigens (PCNAs). The stained sections were examined by microscopy. Images of these sections were recorded and analyzed by image analysis system and relevant software for DNA content, AgNOR intensity, and PCNA expression in the nucleus, nucleoli, and hepatoma cells, respectively. Results: The HAP nanoparticles were uniformly distributed, with a size of 44.6 nm to 86.8 nm. Upon the local injection of the tumor with the HAP nanoparticles, the average volumes of the tumors were significantly reduced compared with those of the control group, which had a tumor inhibition rate of 51.32%. The DNA content, AgNOR intensity, and PCNA expression in the hepatoma cells were all significantly reduced (P < 0.01) compared with those in the control group. Conclusion: HAP nanoparticles inhibit the proliferation of hepatoma cells in vivo.
机译:目的:评估羟基磷灰石(HAP)纳米粒子对肝癌细胞增殖的活性。方法:采用均相沉淀法制备HAP纳米颗粒。这些纳米颗粒的尺寸分布和形态分别通过激光颗粒分析和透射电子显微镜确定。建立了在右pat皮下裸鼠移植的人肝癌细胞(Bel-7402)的异种移植肿瘤模型,并将其分为两组:治疗组和对照组。一旦异种移植肿瘤长到0.8 cm的直径,每天将0.2 ml HAP纳米颗粒悬浮液注入肿瘤,持续2周。在HAP注射之前和之后测量肿瘤的长径和短径,并计算肿瘤生长的抑制率。由如上处理2周的异种移植肿瘤制备石蜡组织切片,对DNA和嗜液性核仁组织区(AgNORs)进行组织学染色,对细胞增殖性细胞核抗原(PCNAs)进行免疫组织学染色。通过显微镜检查染色的切片。记录这些切片的图像,并通过图像分析系统和相关软件对核酸含量,AgNOR强度和PCNA在细胞核,核仁和肝癌细胞中的表达进行分析。结果:HAP纳米颗粒均匀分布,尺寸为44.6 nm至86.8 nm。与HAP纳米颗粒局部注射肿瘤后,与对照组相比,肿瘤的平均体积显着减少,而对照组的平均肿瘤抑制率为51.32%。与对照组相比,肝癌细胞中的DNA含量,AgNOR强度和PCNA表达均显着降低(P <0.01)。结论:HAP纳米颗粒在体内抑制肝癌细胞的增殖。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号